Pacific Biosciences of California, Inc. Announces Pricing of Public Offering of Common Stock
August 11, 2020 23:20 ET
|
Pacific Biosciences of California, Inc.
MENLO PARK, Calif., Aug. 11, 2020 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (Nasdaq: PACB) (“Pacific Biosciences” or the “Company”) today announced that it has priced its...
Pacific Biosciences of California, Inc. Announces Proposed Public Offering of Common Stock
August 11, 2020 16:32 ET
|
Pacific Biosciences of California, Inc.
MENLO PARK, Calif., Aug. 11, 2020 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (Nasdaq: PACB) today announced that it intends to offer and sell $75.0 million of shares of its common...
Pacific Biosciences Announces New Chief Executive Officer
August 07, 2020 08:30 ET
|
Pacific Biosciences of California, Inc.
Christian O. Henry Named Chief Executive OfficerJohn F. Milligan, Ph.D. Named Chairman of the BoardBen Gong Named Interim CFO MENLO PARK, Calif., Aug. 07, 2020 (GLOBE NEWSWIRE) -- Pacific...
Pacific Biosciences of California, Inc. Announces Second Quarter 2020 Financial Results
August 03, 2020 16:02 ET
|
Pacific Biosciences of California, Inc.
MENLO PARK, Calif., Aug. 03, 2020 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (NASDAQ: PACB) today announced financial results for its second quarter ended June 30, 2020. Total...
Pacific Biosciences and Asuragen Collaborate to Develop Assays for Carrier Screening and other Applications Based on SMRT Sequencing Technology and AmplideX PCR Chemistry
August 03, 2020 08:00 ET
|
Pacific Biosciences of California, Inc.
AUSTIN, Texas and MENLO PARK, Calif., Aug. 03, 2020 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (Nasdaq:PACB), a leading provider of high-quality sequencing of genomes,...
Pacific Biosciences of California, Inc. Second Quarter 2020 Financial Results Call
July 24, 2020 12:07 ET
|
Pacific Biosciences of California, Inc.
MENLO PARK, Calif., July 24, 2020 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (NASDAQ: PACB) will hold its quarterly conference call to discuss its Second Quarter 2020 Financial...
Pacific Biosciences Announces Planned Retirement of CEO, Dr. Michael Hunkapiller
June 10, 2020 08:59 ET
|
Pacific Biosciences of California, Inc.
Dr. Hunkapiller to retire by the end of 2020 Susan K. Barnes, CFO to retire in August 2020 MENLO PARK, Calif., June 10, 2020 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (NASDAQ:...
Pacific Biosciences of California, Inc. Announces Rescheduling of 2020 Annual Meeting of Stockholders and Move to Virtual Meeting
June 08, 2020 16:02 ET
|
Pacific Biosciences of California, Inc.
MENLO PARK, Calif., June 08, 2020 (GLOBE NEWSWIRE) -- The Board of Directors of Pacific Biosciences of California, Inc. (NASDAQ: PACB) (the “Company”) has announced that it is rescheduling the date...
Pacific Biosciences of California, Inc. Announces First Quarter 2020 Financial Results
May 06, 2020 16:03 ET
|
Pacific Biosciences of California, Inc.
MENLO PARK, Calif., May 06, 2020 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (NASDAQ: PACB) today announced financial results for its first quarter ended March 31, 2020. As...
Pacific Biosciences of California, Inc. First Quarter 2020 Financial Results Call
April 27, 2020 13:09 ET
|
Pacific Biosciences of California, Inc.
MENLO PARK, Calif., April 27, 2020 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (NASDAQ: PACB) will hold its quarterly conference call to discuss its First Quarter 2020 Financial...